- Home
- THAR vs OM Comparison
THAR vs OM Comparison
Compare THAR & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | THAR | OM |
|---|---|---|
| Founded | 2017 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.8M | 85.0M |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | THAR | OM |
|---|---|---|
| Price | $2.87 | $5.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 565.1K | ★ 1.7M |
| Earning Date | 11-12-2025 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $120,069,000.00 |
| Revenue This Year | N/A | $5.77 |
| Revenue Next Year | N/A | $9.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.65 |
| 52 Week Low | $0.95 | $3.10 |
| 52 Week High | $9.08 | $21.98 |
Technical Indicators
Market Signals| Indicator | THAR | OM |
|---|---|---|
| Relative Strength Index (RSI) | 51.93 | 57.73 |
| Support Level | $2.77 | $3.10 |
| Resistance Level | $3.56 | $6.49 |
| Average True Range (ATR) | 0.25 | 0.46 |
| MACD | 0.02 | 0.35 |
| Stochastic Oscillator | 41.53 | 59.73 |
Price Performance
Historical ComparisonAbout THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.